Advertisement

Investigations on auto-antibodies in Alzheimer’s and Parkinson’s diseases, using defined neuronal cultures

  • A. Dahlström
  • A. Wigander
  • K. Lundmark
  • C.-G. Gottfries
  • P. M. Carvey
  • A. McRae
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 29)

Summary

In immunocytochemical studies, the CSF from Parkinson disease (PD) patients and from Alzheimer disease (AD) patients were investigated for the presence of neuron specific antibodies using dopaminergic and cholinergic neuronal cultures from embryonic rat brain, respectively. Dopamine containing cell bodies were labelled by Parkinsonian CSF-IgG, while cholinergic neurons, identified with a-NGF-receptor antibodies, were recognized by CSF from AD-patients.

The CSF from PD-patients was investigated after autologous adrenal transplantation. CSF was removed 7d, 5 months and 1 year after operation. When added to 18d neuronal cultures for 3d, the 7d CSF caused neuronal cell death and a glial reaction. The 4 months CSF caused cell death, but markedly less than the 7d CSF. One year after transplantation the CSF had no toxic effects; these cultures were similar to control cultures.

It is concluded that CSF from PD patients may contain aggressive IgG-species specific for DA neurons, and that the amount of such antibodies decrease after adrenal transplant operations. It is suggested that neurodegenerative diseases may become aggravated by autoimmune reactions.

Keywords

Alzheimer Disease Cholinergic Neuron Medial Septum Alzheimer Disease Patient Cholinergic Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramsky O, Litvin Y (1978) Autoimmune responses to dopamine receptor as a possible mechanism in the pathogenesis of Parkinson’s disease and schizophrenia. Perspect Biol Med 22: 104–114.PubMedGoogle Scholar
  2. Bahmanyar S, Gadjusek CD, Sotelo J, Gibbs CJ (1982) Longitudinal spinal cord sections as a substratum for anti-neurofilament antibodies. J Neurosci 53: 85–90.Google Scholar
  3. Baldinger S, Blumenthal HT (1982) Neuroimmunology of the aging brain. In: Platt D (ed) Geriatrics. Springer, Berlin Heidelberg New York, pp 283–299.CrossRefGoogle Scholar
  4. Bergsma D, Goldstein AL (eds) (1978) Neurochemical and immunological components in schizophrenia. Alan R Liss, New York.Google Scholar
  5. Carvey PM, Kroin JS, Zhang TJ, O’Dorsio TM, Yaksch TL, McRae A, Dahlström A, Kao LC, Goetz CG, Tanner CM, Shannon KM, Klawans HL (1988) Biochemical and immunochemical characterization of ventricular CSF from Parkinson’s disease patients with adrenal medulla transplants. Neurology [Suppl 1] 38: 144.Google Scholar
  6. Chandler CE, Parsons LM, Hosang M, Shooter EM (1984) A monoclonal antibody modulates the interaction of nerve growth factor with PC 12 cells. J Biol Chem 259: 6882–6889.PubMedGoogle Scholar
  7. Chapman J, Korczyn AD, Hareuveni M, Michaelson DM (1986) Antibodies to cholinergic cell bodies in Alzheimer’s disease. In: Fisher A, Hanin I, Lachman C (eds) Alzheimer’s and Parkinson’s disease: strategies for research and development. Plenum Press, New York, pp 329–336.Google Scholar
  8. Fillit HM, Luine V, Reisberg B, Amador R, McEwen BS, Zabriskie JB (1985) Studies of the specificity of autobrain antibodies in Alzheimer’s disease. In: Hutton JT, Kenny AD (eds) Senile dementia. Alan R Liss, New York, pp 307–336.Google Scholar
  9. Foley P, Bradford H, Docherty M, Fillit H, Luine V, McEwen B, Bucht G, Winblad B, Hardy J (1988) Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer’s disease. J Neurol 235: 466–471.PubMedCrossRefGoogle Scholar
  10. Francon J, Fellous A, Lennon AM, Numez J (1977) Is thyroxin a regulatory signal for neurotuble assembly during brain development? Nature 266: 188–190.PubMedCrossRefGoogle Scholar
  11. Giulian D, Baker X (1986) Characterization of ameboid microglia isolated from the developing mammalian brain. J Neurosci 6: 2163–2178.PubMedGoogle Scholar
  12. Hartikka J, Hefti H (1988) Development of septal cholinergic neurons in culture: plating density and glia cells modulate effects of NGF on survival, fiber growth and expression of transmitter-specific enzymes. J Neurosci 8: 2967–2985.PubMedGoogle Scholar
  13. Lampson LA (1987) Molecular basis of the immune response to neural antigens. TINS 10: 211–216.Google Scholar
  14. Leon A, Dal Toso R, Presti D, Mazzoni S, Vencenzi D, Toffano D (1985) Sera from Parkinsonian patients contain inhibitory activity for development of fetal mesencephalic dopaminergic neurons in culture. J Neurochem [Suppl 44]: 137.Google Scholar
  15. McGeer P, Itagaki S, Tago H, McGeer E (1987) Reactive microglia in patients with senile dementia of the Alzheimer’s type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79: 195–200.PubMedCrossRefGoogle Scholar
  16. McRae-Degueurce A, Bööj S, Haglid K, Rosengren L, Karlsson JE, Karlsson I, Wallin A, Svennerholm L, Gottfries CG, Dahlström A (1987) Antibodies in the cerebrospinal fluid of some Alzheimer’s diseases patients recognize cholinergic neurons in the rat central nervous system. PNAS 84: 9214–9218.PubMedCrossRefGoogle Scholar
  17. McRae-Degueurce A, Gotttfries CG, Karlsson I, Svennerholm L, Dahlström A (1986 a) Antibodies in the CSF of a Parkinson patient recognizes neurons in rat mesencephalic regions. Acta Physiol Scand 126: 313–315.PubMedCrossRefGoogle Scholar
  18. McRae-Degueurce A, Geffard M (1986b) One perfusion mixture to fix acetylcholine, noradrenaline, dopamine and serotonin in the rodent central nervous system. Brain Res 376: 217–219.PubMedCrossRefGoogle Scholar
  19. McRae-Degueurce A, Haglid K, Rosengren L, Wallin A, Blennow K, Gottfries CG, Dahlström A (1988 a) Antibodies recognizing cholinergic neurons and thyroglobuline are found in the cerebrospinal fluid of a subgroup of patients with Alzheimer’s disease. Drug Dev Res 15: 153–163.CrossRefGoogle Scholar
  20. McRae-Degueurce A, Rosengren L, Haglid K, Augustsson I, Dahlström A (1988b) Dopaminergic nerve terminals in the locus coeruleus: an immunocytochemical investigation. Acta Physiol Scand 133: 538–585.CrossRefGoogle Scholar
  21. McRae-Degueurce A, Rosengren L, Haglid K, Bööj S, Gottfries CG, Granérus A-C, Dahlström A (1988c) Immunocytochemical investigations on the presence of neuron-specific antibodies in the CSF of Parkinson’s disease patients. Neurochem Res 13: 679–684.PubMedCrossRefGoogle Scholar
  22. McRae-Degueurce A, Klawans HL, Penn RD, Dahlström A, Tanner CM, Goetz CG, Carvey P (1988d) An antibody in the CSF of Parkinson’s disease patients disappears following adrenal medulla transplants. Neurosci Lett 94: 192–197.PubMedCrossRefGoogle Scholar
  23. Nandy K (1978) Alzheimer’s disease: senile dementia and related disorders. In: Katzman RD, Terry RD, Bick KL (eds) Aging, vol 7. Raven Press, New York, pp 503–512.Google Scholar
  24. Penn RD, Goetz C, Tanner C, Klawans H, Shannon K, Cornelia C, Witt T (1988) The adrenal medullary transplant operation for Parkinson’s diseases: clinical observations in five patients. Neurosurgery 22: 999–1004.PubMedCrossRefGoogle Scholar
  25. Shu S, Ju G, Fan L (1988) The glucose oxidase-DAB-nickel method in peroxidase histo-chemistry of the nervous system. Neurosci Lett 85: 169–171.PubMedCrossRefGoogle Scholar
  26. Singh V, Fudenberg HH (1986) Detection of brain autoantibodies in the serum of patients with Alzheimer’s disease but not with Down’s syndrome. Immunol Lett 12: 277–280.PubMedCrossRefGoogle Scholar
  27. Taniuchi M, Schweitzer JB, Johnson EM (1986) Demonstration of nerve growth factor receptor in the rat brain. Proc Natl Acad Sci (USA) 83: 1950–1954.CrossRefGoogle Scholar
  28. Thiele DL, Kurosaka M, Lipsky PE (1983) Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotrophic agent L-leucine methyl ester. J Immunol 131: 2282–2286.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • A. Dahlström
    • 1
    • 5
  • A. Wigander
    • 1
  • K. Lundmark
    • 1
  • C.-G. Gottfries
    • 2
  • P. M. Carvey
    • 3
  • A. McRae
    • 1
    • 4
  1. 1.Institute of Neurobiology, Neuroscience Research Center of GöteborgUniversity of GöteborgSweden
  2. 2.St. Jörgen’s Hospital, Neuroscience Research Center of GöteborgUniversity of GöteborgSweden
  3. 3.Department of Neurological SciencesRush-Presbyterian St. Luke’s Medical CollegeChicagoUSA
  4. 4.INSERM 259BordeauxFrance
  5. 5.Institute of Neurobiology, Neuroscience Research Center for GöteborgUniversity of GöteborgGöteborgSweden

Personalised recommendations